weight loss semaglutide shreveport Louisiana Online Medical Program ❘ InjectCo Lose Weight With the Slim

Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, not weight loss

At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits

Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al

Researchers are also studying GLP-1 analogs for potential roles in fatty liver disease, Parkinsons disease, and addiction treatment

Semaglutide, marketed under the brand name Ozempic for diabetes and Wegovy for weight loss, is a once-weekly injectable medication already approved by the FDA for weight management